173 related articles for article (PubMed ID: 8484669)
21. Matrix metalloproteinases 2 and 9 in canine rheumatoid arthritis.
Coughlan AR; Robertson DH; Bennett D; May C; Beynon RJ; Carter SD
Vet Rec; 1998 Aug; 143(8):219-23. PubMed ID: 9770764
[TBL] [Abstract][Full Text] [Related]
22. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2.
Bigg HF; Shi YE; Liu YE; Steffensen B; Overall CM
J Biol Chem; 1997 Jun; 272(24):15496-500. PubMed ID: 9182583
[TBL] [Abstract][Full Text] [Related]
23. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
[TBL] [Abstract][Full Text] [Related]
24. A study of metalloproteinases in fifty joint fluid specimens.
Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X
Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609
[TBL] [Abstract][Full Text] [Related]
25. Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme.
Fridman R; Bird RE; Hoyhtya M; Oelkuct M; Komarek D; Liang CM; Berman ML; Liotta LA; Stetler-Stevenson WG; Fuerst TR
Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):411-6. PubMed ID: 8380993
[TBL] [Abstract][Full Text] [Related]
26. Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder.
Kubota T; Kubota E; Matsumoto A; Kawai Y; Saito H; Mikuni-Takagaki Y; Sato S
Eur J Oral Sci; 1998 Dec; 106(6):992-8. PubMed ID: 9879910
[TBL] [Abstract][Full Text] [Related]
27. TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family.
Stetler-Stevenson WG; Krutzsch HC; Liotta LA
Matrix Suppl; 1992; 1():299-306. PubMed ID: 1480041
[TBL] [Abstract][Full Text] [Related]
28. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
29. Autoactivation profiles of calcium-dependent matrix metalloproteinase-2 and -9 in inflammatory synovial fluid: effect of pyrophosphate and bisphosphonates.
Makowski GS; Ramsby ML
Clin Chim Acta; 2005 Aug; 358(1-2):182-91. PubMed ID: 15921672
[TBL] [Abstract][Full Text] [Related]
30. The extracellular matrix produced by bovine corneal endothelial cells contains progelatinase A.
Menashi S; Vlodavsky I; Ishai-Michaeli R; Legrand Y; Fridman R
FEBS Lett; 1995 Mar; 361(1):61-4. PubMed ID: 7890041
[TBL] [Abstract][Full Text] [Related]
31. Destruction of articular cartilage by alpha 2 macroglobulin elastase complexes: role in rheumatoid arthritis.
Moore AR; Appelboam A; Kawabata K; Da Silva JA; D'Cruz D; Gowland G; Willoughby DA
Ann Rheum Dis; 1999 Feb; 58(2):109-13. PubMed ID: 10343526
[TBL] [Abstract][Full Text] [Related]
32. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis.
Tchetverikov I; Ronday HK; Van El B; Kiers GH; Verzijl N; TeKoppele JM; Huizinga TW; DeGroot J; Hanemaaijer R
Ann Rheum Dis; 2004 Jul; 63(7):881-3. PubMed ID: 15194590
[TBL] [Abstract][Full Text] [Related]
33. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
34. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.
von Bredow DC; Cress AE; Howard EW; Bowden GT; Nagle RB
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):965-72. PubMed ID: 9560329
[TBL] [Abstract][Full Text] [Related]
35. Identification of a new metalloproteinase inhibitor that forms tight-binding complexes with collagenase.
Cawston TE; Curry VA; Clark IM; Hazleman BL
Biochem J; 1990 Jul; 269(1):183-7. PubMed ID: 2165393
[TBL] [Abstract][Full Text] [Related]
36. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis.
Clark IM; Powell LK; Ramsey S; Hazleman BL; Cawston TE
Arthritis Rheum; 1993 Mar; 36(3):372-9. PubMed ID: 8452582
[TBL] [Abstract][Full Text] [Related]
37. Efficient purification of TIMP-2 from culture medium conditioned by human hepatoma cell line, and its inhibitory effects on metalloproteinases and in vitro tumor invasion.
Umenishi F; Umeda M; Miyazaki K
J Biochem; 1991 Aug; 110(2):189-95. PubMed ID: 1662201
[TBL] [Abstract][Full Text] [Related]
38. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes.
Ward RV; Atkinson SJ; Slocombe PM; Docherty AJ; Reynolds JJ; Murphy G
Biochim Biophys Acta; 1991 Aug; 1079(2):242-6. PubMed ID: 1911847
[TBL] [Abstract][Full Text] [Related]
39. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
40. Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. Identification of a stabilization site.
Howard EW; Banda MJ
J Biol Chem; 1991 Sep; 266(27):17972-7. PubMed ID: 1655733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
